Showing results (1781-1790 of 3,529) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|July 19, 2026
Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database StudyAnand Shah, Pranav Gwalani, Merry Zhai, et al.
Thoracic Cancer|August 28, 2026
Decoding Malignant Lung Ground Glass Opacities: A Radiologic-Pathologic Study From Pure to Semi-Solid LesionsAlessandro Bonis, Giulia Pagliarini, Vincenzo Verzeletti, et al.
Thoracic Cancer|September 19, 2026
Artificial Intelligence-Assisted Pulmonary Nodule Diagnosis by Thoracic Surgeons: A Comparative Study on Clinical EffectivenessYeong Jeong Jeon, Jonghun Jeong, Doohyun Park, et al.
Thoracic Cancer|April 6, 2022
Cytokine release syndrome and successful response to pembrolizumab therapy in a patient with EGFR-mutated non-small-cell lung cancer: A case reportMeng Zhang, Yuan Cheng, Yan Hu, et al.
Thoracic Cancer|June 15, 2022
Selection of minimally invasive surgical approaches for treating esophageal cancerYu-Kwang Lee, Ke-Cheng Chen, Pei-Ming Huang, et al.
Thoracic Cancer|June 15, 2022
Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching studyMu-Zi Yang, Zi-Hui Tan, Ji-Bin Li, et al.
Thoracic Cancer|April 25, 2019
Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patientsPeng Song, Xiaoxia Cui, Li Bai, et al.
Thoracic Cancer|April 10, 2019
Benign disease prone to be misdiagnosed as malignant pulmonary nodules: Minute meningothelioid nodulesXiao-Xiao Peng, Li-Xu Yan, Chao Liu, et al.
Thoracic Cancer|April 11, 2019
Efficacy of PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer: A meta-analysis of randomized clinical trialsTzu-Rong Peng, Ta-Wei Wu
Thoracic Cancer|June 5, 2019
Comparison of Endostar continuous versus intermittent intravenous infusion in combination with first-line chemotherapy in patients with advanced non-small cell lung cancerYuan Cheng, Ligong Nie, Ying Liu, et al.
Pageof 353